In the News

Feb February 21 Wed 2018

 

Human Immunity to Cas9 Could Threaten CRISPR’s Future

By Dave Roos

New data shows that humans carry antibodies and even T-cells that target the Cas9 protein at the heart of CRISPR gene editing technology.

Read more >>

 

Oct October 09 Mon 2017

Matthew Porteus awarded grant for sickle cell anemia work

The California Institute for Regenerative Medicine has awarded MATTHEW PORTEUS, associate professor of pediatrics, a grant of $5.2 million to lay the groundwork for a clinical trial of a possible treatment for sickle cell disease.

Read more >>

 

Nov November 07 Mon 2016

Researchers take step toward gene therapy for sickle cell disease

Using the CRISPR gene-editing technique in stem cells, Stanford researchers repaired the gene that causes sickle cell disease, and the mended stem cells were successfully transplanted into mice.
Read more >>

 

Jun June 29 Mon 2015

CRISPR marches forward: Stanford scientists optimize use in human blood cells

The CRISPR news just keeps coming. As we’ve described here before, CRISPR is a breakthrough way of editing the genome of many organisms, including humans — a kind of biological cut-and-paste function that is already transforming scientific and clinical research. Read more >>

May May 26 Tue 2015

Porteus receives $1M stem cell grant for ‘bubble boy disease’

The grant will allow the researcher to pursue a stem-cell-based gene therapy approach to correcting a form of severe combined immunodeficiency in humans. Read more >>

Oct October 29 Wed 2014

New way of genome editing could cure hemophilia in mice; may be safer than older method, study shows

A technique developed by Stanford researchers could provide a safer, longer-lasting method of replacing faulty, disease-causing genes with working copies. Read more >>